Immunohistochemical evaluation of intracranial recurrent meningiomas: Correlation of topoisomerase ii a expression and cell proliferative potential

Brain and Nerve

Volumn 51, Issue 12, 1999, Pages 1033-1039

  Tanaka, Masahiko ^a   Kubo, Osami ^b   Tajika, Yasuhiko ^a   Takahashi, Toshio ^b   Suzuki, Shigeharu ^a   Takakura, Kintomo ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Cell proliferation; Meningioma; MIB 1; Recurrence; Topoisomerase

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING);

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HEMANGIOPERICYTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; INTRACRANIAL TUMOR; MALE; MENINGIOMA; PROTEIN EXPRESSION; TUMOR RECURRENCE;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BRAIN NEOPLASMS; CELL DIVISION; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; FEMALE; HEMANGIOPERICYTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MENINGIOMA; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; RECURRENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 0033370931     PISSN: 00068969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Barbare NM : Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery 20 : 525-528, 1987
2. Chan RC : Morbidity, mortality and quality of life following surgery for intracranial meningiomas : A retrospective study in 257 cases. J Neurosurgery 60 : 52-60, 1984
3. Skullerud K :The prognosis in meningioma. Acta Neuropathol(Berl) 29:337-344, 1974
4. Simpson D : The recurrence intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22-39, 1957
5. Matsuno A, Fujimaki T, Sasaki T : Clinical and histopathological analysis of proliferative and histopathological analysis of proliferative potentials of recurrent meningiomas. Acta Neuropathol(Berl) 91: 504-510, 1996
6. s±jfcffi, ft 8, g , ifJH ;£: ' ?n-f/LMiB-i icistasiJtwsiÄiiWHEwftiw. m Wlï 48 : 39-43, 1996
7. Nakasu S, Nakajima M, Matsumura K, Nakasu Y, Handa J : Meningioma : Proliferating potential and clinicoradiological features. Neurosurgery 37 : 10491055, 1995
8. Asano T, Mayes J, Zwelling LA, Kleinerman ES : Transfection of human topoisomerase II a into etoposide-resistant cells : Transient increase in sensitivity followed by down-regulation of the endogenous gene. Biochem J 319 : 307-313, 1996
9. Smirnov IV, Feuerstein BG, Pellarin M : Pretreatment with the polyamine analog 1, 19 :bis-(ethylamino), 10, 15-triazanonadecane(BE-4-4-4-4) inhibits etoposide cytotoxicity in U-251 MG(NCI) human brain tumor cells. Cell Mol Biol (Noisy-le-grand) 40:975-980, 1997
10. Chamberlain MC : Recurrent brainstem gliomas treated with oral VP-16. J Neurooncol 15 : 133-139, 1993
11. Feun LG, Savaraj N, Landy HJ : Drug resistance in brain tumors. J Neurooncol 20 :165-176, 1994
12. Needle MN, Molloy FT, Geyer JR : Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors. Med Pediatr Oncol 29 : 28-32, 1997
13. Ali-Osman F, Berger MS, Rajagopal S : Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells. Cancer Res 53 : 5663-5668, 1993
14. Jensen PB, Sehested M : DNA topoisomerase II rescue by catalytic inhibitorsa new strategy to improve the antitumor selectivity of etoposide. Biochem Pharmacol 54 :755-759, 1997
15. Lohri A, Reuter J, Gudat F, Hermann R : Topoisomerase II a mRNA and tumor cell proliferation in nonHodgkin lymphoma. J Clin Pathol 50: 22-26, 1997
16. Fukui M, Iwaki T, Sawa H, Inoue T : Proliferative activity of meningiomas as evaluated by bromodeoxyuridine uptake examination. Acta Neurochir ( Wien ) 81:135-141, 1986
17. Lauren AL, Catherine SC, Franco D : Comparison of MIB-KKi-67) antigen and bromodeoxyuridine proliferation indices in meningiomas. Human Pathol 27 : 350-354, 1996
18. Allegranza A, Girlando S, Arrigoni GL : Proliferation cell nuclear antigen expression in central nervous system neoplasms. Virchows Archiv A Pathol Anat 419 : 417-423, 1991
19. Holden JA, Perkins SL, Snow GW : Immunohistochemical staining for DNA topoisomerase II in nonHodgkin's lymphomas. Am J Clin Pathol 104 : 54-59, 1995
20. lino K, Sasano H, Yabuki N : DNA topoisomerase II a and Ki-67 in human adrenocortical neoplasms : A possible marker of differentiation between adenomas and carcinomas. Mod Pathol 10:901-907, 1997
21. Fogt F, Nikulasson ST, Holden JA : Topoisomerase II a expression in normal, inflammatory, and neoplastic conditions of the gastric and colonie mucosa. Mod Pathol 10: 296-302, 1997
22. Stammler G, Sauerbrey A, Voira M : Messenger RNA expression of resistance factors and their correlation to the proliferative activity in childhood acute lymphoblastic leukemia. Cancer Lett 89 : 129-135, 1995
23. Gibbons D, Fogt F, Kasznica J : Comparison of topoisomerase II a and MIB-1 expression in uterine cervical squamous lesions. Mod Pathol 10 : 409-413, 1997
24. Lynch BJ, Guinée DG Jr, Holden JA: Human DNA topoisomerase II or : A new marker of cell proliferation in invasive breast cancer. Hum Pathol 28 : 1180-1188, 1997